₹48.45 Crores | Listing at BSE | Tue, Jan 23, 2024 - Tue, Feb 13, 2024
Genpharmasec Limited Rights Issue comprises 27.69 Cr equity shares aggregating to ₹48.45 Cr, offered at an issue price of ₹1.75 per share with a face value of ₹1 per share.
The record date for determining eligible shareholder is Jan 9, 2024, with the Rights Issue being offered in the entitlement ratio of 1 : 1.
The term of payment is defined as following : Full amount of Rs.1.75 per Equity Share is payable on application.
The Rights Entitlements are expected to be credited to eligible demat accounts on [.]
The Rights Issue opens on Jan 23, 2024, and closes on Feb 13, 2024, with renunciation of Rights Entitlements permitted up to Feb 2, 2024.
The deemed date of allotment is Feb 16, 2024, following which the equity shares are expected to be credited to demat accounts on Feb 21, 2024 and listed at the BSE on Feb 26, 2024.
Purva Sharegistry (India) Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Genpharmasec Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Tue, Jan 9, 2024
Entitlement Ratio
1 : 1
Open Date
Tue, Jan 23, 2024
Close Date
Tue, Feb 13, 2024
Full amount of Rs.1.75 per Equity Share is payable on application.
Genpharmasec Limited's revenue decreased by -6.56% and profit after tax (PAT) rose by 637.15% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 19.88 | 21.65 | 27.82 |
| Revenue | 25.62 | 27.41 | 21.64 |
| Profit After Tax | 1.12 | -0.21 | 1.26 |
| Net Worth | 29.91 | 28.78 | 28.99 |
| Reserves and Surplus | 28.78 | 28.99 | |
| Total Borrowing | 3.08 | ||
| Amount in ₹ Crore | |||
Incorporated in 1992, is engaged in the purchase, sale and distribution of various pharmaceutical, medical and medicinal products.
The company develops, manufactures, distributes and supplies chemicals used in the production of pharmaceuticals, drug enzymes and sanitary napkins.
The company has entered into a partnership with Abbott Point of Care Corporation Inc. based in the USA to distribute their specialized diagnostic device, the i-STAT 1 Analyzer. This device is used exclusively in intensive care units and hospital ICCUs for immediate test results. The i-STAT 1 Analyzer is lightweight, portable and easy to use. It utilizes the advanced technology of the i-STAT test cassettes. Together they form the i-STAT system - a point-of-care testing platform that provides healthcare professionals with diagnostic information at the time and place it is needed.
The company proposes to utilize the net proceeds from the Issue towards funding the following objects:
[Dilip Davda] Though this RI is at a discount of around 72% based on its last traded price of Rs. 6.30, it appears to be a manipulated price to pave the way for RI. The financial performance is not in line with its prevalent traded price. The company operates on a third party product supplied. Well-informed investors consider parking of funds, while others may avoid it. Read detail review...
Genpharmasec Rights Issue 2024 got oversubscribed by 1.5 times by the end of the bidding period with total bid quantity received by BSE of 41,47,41,563 shares. Check Day by Day Subscription Details (Live Status)
| Date | BSE Bid Quantity | Subscription Times |
|---|---|---|
Feb 13 2024 17:00:00 | 41,47,41,563 | 1.50x |
Genpharmasec Limited
Office No. 104 & 105 (1st Floor),
Gundecha Industrial Premises, Co-Op Society Ltd
Akurli Road, Kandivali (East), Mumbai,- 400101
Mumbai, Maharashtra, 400101
Purva Sharegistry (India) Pvt.Ltd.
The Genpharmasec Rights Issue 2024 opens on Tue, Jan 23, 2024, and closes on Tue, Feb 13, 2024.
Genpharmasec Rights Issue 2024 Schedule
| Last Date for credit of Rights Entitlements | |
| Last Date for renunciation of Rights Entitlements | Fri, Feb 2, 2024 |
| Issue Opening Date | Tue, Jan 23, 2024 |
| Issue Closing Date | Tue, Feb 13, 2024 |
| Date of Allotment (on or about) | Fri, Feb 16, 2024 |
| Date of Credit (on or about) | Wed, Feb 21, 2024 |
| Date of Listing (on or about) | Mon, Feb 26, 2024 |
You can apply for Genpharmasec Rights Issue 2024 in two ways:
Steps to apply for Genpharmasec Rights Issue 2024 using Net Banking (ASBA)
Steps to apply for Genpharmasec Rights Issue 2024 using Registrar's website (R-WAP)
